Stop the IRS!
Help Campaign for Liberty fight back against the IRS. Fill out your Emergency Supporter Ballot today!

1959271_10152314328159614_961656009_n

 

Senator Paul Questions Tim Geithner

During a subcommittee hearing today, Senator Paul was able to question Treasury Secretary Timothy Geithner on the "wisdom" of central bankers determining interest rates instead of market forces.  He asked Geithner what he thought caused the housing bubble, and not-so-subtly-hinted that the NYFed and the FOMC played a role. http://www.youtube.com/watch?v=yqLfwyCTIyc As an aside, here's an article […]


Read full story

Senator Paul on CNBC

Last night, Senator Paul was on Larry Kudlow's show discussing the "Occupy Wall St." protests, the President's class warfare rhetoric, and the administration's call for a new stimulus. http://www.youtube.com/watch?v=DZAasUtZwsg


Read full story

A New War Front in Africa

President Obama is rapidly becoming George W. Bush on steroids.  This week’s announcement that 100 military advisers would be going to Uganda to assist in operations against "The Lord’s Army" surprised even pessimists like myself who have been watching the growing militarization of the foreign policy being conducted White House.  "The Lord's Army" threatens no […]


Read full story

Three Takeaway Lessons from the GAO Audit of the Federal Reserve

From Project on Government Oversight (a coalition parter of Campaign for Liberty on Audit the Fed) Fed Oversight Lesson 1: There are still limits to the GAO’s audit authority The GAO’s audit of the Federal Reserve, which was published in July 2011, was a one-time deal. It was authorized for a specific purpose, which was to examine emergency […]


Read full story

Juvenile Diabetes Research Foundation Fights FDA

Keeping with this weeks theme highlighting Washington's burdensome regulatory regime, this instance is one where the FDA could end up inhibiting medical research progress by establishing roadblocks to outpatient clinical trials of an artificial pancreas for people with type 1 diabetes.   On December 1, the FDA will issue crucial guidelines to the clinical trial […]


Read full story